Sars-Cov-2 Recombinant DNA vaccine

On March 11, 2020 the World Health Organization (WHO) declared Coronavirus Disease (COVID-19) a global pandemic. More than one million cases of COVID-19 have been confirmed in 208 countries and territories around the world, including Thailand.

The pandemic of new COVID-19 has led to the race in the development of SARS-CoV-2 vaccines through international collaborations among academics, research institutes and private sectors with 60 vaccine projects using technologies such as DNA, mRNA, or recombinant vaccines.

Our teams at BioNet are actively contributing to the global efforts of stopping the pandemic by working on a recombinant vaccine against SARS-CoV-2, the virus that is causing COVID-19.

Our manufacturing facilities are already equipped for production of recombinant vaccines which can be also used for manufacturing vaccines against COVID-19 at medium or large scale when product development is completed.


For more information about our commitment to develop a vaccine against COVID-19, please contact us at covigen@bionet-asia.com